← Leaderboards
Gerald R. Crabtree
Stanford University
$18,872,595
Attributed
$19,654,478
Total exposure
11
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$19,654,478 · 11
By mechanism
R01$13,743,104 · 5
R37$3,741,346 · 2
RF1$1,261,798 · 1
R21$689,827 · 1
P01$139,403 · 1
R03$79,000 · 1
Top collaborators
- Nathanael Schiander Gray3 shared
Most similar at Stanford University
Same institution · by research overlap
- Seung K Kim$34,748,747
- Ian Paul Winters$2,063,990
- Sai Gourisankar$259,309
Others in their field
Top investigators on “Genes”
- David Heimbrook · Leidos Biomedical Research, Inc.$413,811,031
- Richard A Gibbs · Baylor College Of Medicine$338,750,128
- Barton F Haynes · Duke University$304,076,400
- Stacey Gabriel · Massachusetts Institute Of Technology$241,252,013
- Eric S Lander · Whitehead Institute For Biomedical Res$211,825,987
- Richard K. Wilson · Washington University$195,881,965
Research focus
GenesComplexPolycombProteinsChromatinCellsBiochemicalPathway InteractionsRepressionSmall MoleculeGeneticTranscription FactorBaseSignal TransductionMutationLeadBrainMediatingIn VitroPhenotypePlayGenetic TranscriptionChromatin RemodelingDefect
Grant awards (62)
HIJACKING CANCER DRIVERS TO ACTIVATE PROAPOPTOTIC GENES IN DLBCL$614,155
R01 · FY2025 · CA · contact PI
ATP-Dependent Chromatin Remodeling in Human Malignancy$386,000
R01 · FY2025 · CA · contact PI
HIJACKING CANCER DRIVERS TO ACTIVATE PROAPOPTOTIC GENES IN DLBCL$510,464
R01 · FY2024 · CA · contact PI
ATP-Dependent Chromatin Remodeling in Human Malignancy$366,700
R01 · FY2024 · CA · contact PI
HIJACKING CANCER DRIVERS TO ACTIVATE PROAPOPTOTIC GENES IN DLBCL$439,147
R01 · FY2023 · CA · contact PI
ATP-Dependent Chromatin Remodeling in Human Malignancy$387,313
R01 · FY2023 · CA · contact PI
Small molecule regulation of endogenous transcription factors for circuit-specific neuromodulation$1,261,798
RF1 · FY2021 · MH · contact PI
ATP-Dependent Chromatin Remodeling in Human Malignancy$377,979
R01 · FY2021 · CA · contact PI
ATP-Dependent Chromatin Remodeling in Human Malignancy$377,649
R01 · FY2020 · CA · contact PI
ATP-Dependent Chromatin Regulation in Neurodevelopment and Human Disease$380,229
R37 · FY2019 · NS · contact PI
ATP-Dependent Chromatin Remodeling in Human Malignancy$366,022
R01 · FY2019 · CA · contact PI
ATP-Dependent Chromatin Remodeling in Human Malignancy$211,950
R01 · FY2019 · CA · contact PI
ATP-Dependent Chromatin Regulation in Neurodevelopment and Human Disease$382,584
R37 · FY2018 · NS · contact PI
ATP-Dependent Chromatin Remodeling in Human Malignancy$377,058
R01 · FY2018 · CA · contact PI
ATP-Dependent Chromatin Remodeling in Human Malignancy$211,950
R01 · FY2018 · CA · contact PI
ATP-Dependent Chromatin Regulation in Neurodevelopment and Human Disease$384,766
R37 · FY2017 · NS · contact PI
ATP-Dependent Chromatin Remodeling in Human Malignancy$376,791
R01 · FY2017 · CA · contact PI
ATP-Dependent Chromatin Regulation in Neurodevelopment and Human Disease$394,689
R37 · FY2016 · NS · contact PI
ATP-Dependent Chromatin Remodeling in Human Malignancy$328,914
R01 · FY2016 · CA · contact PI
ATP-Dependent Chromatin Regulation in Neurodevelopment and Human Disease$393,215
R37 · FY2015 · NS · contact PI
ATP-Dependent Chromatin Remodeling in Human Malignancy$328,272
R01 · FY2015 · CA · contact PI
ATP-Dependent Chromatin Regulation in Neurodevelopment and Human Disease$389,284
R37 · FY2014 · NS · contact PI
ATP-Dependent Chromatin Remodeling in Human Malignancy$317,818
R01 · FY2014 · CA · contact PI
ATP-Dependent Chromatin Regulation in Neurodevelopment and Human Disease$392,516
R37 · FY2013 · NS · contact PI
ATP-Dependent Chromatin Remodeling in Human Malignancy$307,421
R01 · FY2013 · CA · contact PI
ATP-Dependent Chromatin Remodeling in Human Malignancy$326,459
R01 · FY2012 · CA · contact PI
ATP-dependent Chromatin Remodeling in Neural Development$287,574
R01 · FY2012 · NS · contact PI
NFAT Signaling and Down Syndrome$264,491
R01 · FY2012 · HD · contact PI
Screen for Small Molecule Inhibitors of ATP Dependent Chromatin Remodeling$39,500
R03 · FY2012 · DA · contact PI
ATP-dependent Chromatin Remodeling in Neural Development$287,179
R01 · FY2011 · NS · contact PI
NFAT Signaling and Down Syndrome$264,417
R01 · FY2011 · HD · contact PI
Screen for Small Molecule Inhibitors of ATP Dependent Chromatin Remodeling$39,500
R03 · FY2011 · DA · contact PI
ATP-dependent Chromatin Remodeling in Neural Development$29,400
R01 · FY2011 · NS · contact PI
Signaling in Thymocyte Selection$339,185
R01 · FY2010 · AI · contact PI
ATP-dependent Chromatin Remodeling in Neural Development$289,611
R01 · FY2010 · NS · contact PI
NFAT Signaling and Down Syndrome$275,360
R01 · FY2010 · HD · contact PI
Signaling in Thymocyte Selection$339,067
R01 · FY2009 · AI · contact PI
ATP-dependent Chromatin Remodeling in Neural Development$336,785
R01 · FY2009 · NS · contact PI
ATP-dependent Chromatin Remodeling in Neural Development$292,115
R01 · FY2009 · NS · contact PI
NFAT Signaling and Down Syndrome$278,069
R01 · FY2009 · HD · contact PI
Signaling in T Lymphocyte Development$326,527
R01 · FY2008 · AI · contact PI
ATP-dependent Chromatin Remodeling in Neural Development$291,831
R01 · FY2008 · NS · contact PI
NFAT Signaling and Down Syndrome$277,998
R01 · FY2008 · HD · contact PI
Signaling in T Lymphocyte Development$331,902
R01 · FY2007 · AI · contact PI
Signaling by Calcineurin and NFAT in Axonal Outgrowth$305,874
R01 · FY2007 · NS · contact PI
Signaling in T Lymphocyte Development$340,876
R01 · FY2006 · AI · contact PI
Signaling by Calcineurin and NFAT in Axonal Outgrowth$314,461
R01 · FY2006 · NS · contact PI
Signaling in T Lymphocyte Development$348,152
R01 · FY2005 · AI
Signaling by Calcineurin and NFAT in Axonal Outgrowth$321,488
R01 · FY2005 · NS
Signaling in T Lymphocyte Development$347,261
R01 · FY2004 · AI
Signaling by Calcineurin and NFAT in Axonal Outgrowth$320,971
R01 · FY2004 · NS
Mechanisms of Vascular Development$221,125
R21 · FY2004 · HL
Signaling by Calcineurin and NFAT in Axonal Outgrowth$320,448
R01 · FY2003 · NS
PATHWAYS OF T LYMPHOCYTE ACTIVATION$269,967
R37 · FY2003 · CA
Mechanisms of Vascular Development$221,102
R21 · FY2003 · HL
Mechanisms of Vascular Development$247,600
R21 · FY2002 · HL
PATHWAYS OF T LYMPHOCYTE ACTIVATION$220,807
R37 · FY2002 · CA
PATHOGENESIS AND PREVENTION OF TYPE I DIABETES IN THE NOD MOUSE AND MAN$0
P01 · FY2002 · DK
PATHWAYS OF T LYMPHOCYTE ACTIVATION$302,768
R37 · FY2001 · CA
PATHOGENESIS AND PREVENTION OF TYPE I DIABETES IN THE NOD MOUSE AND MAN$0
P01 · FY2001 · DK
PATHWAYS OF T LYMPHOCYTE ACTIVATION$230,521
R37 · FY2000 · CA
PATHOGENESIS AND PREVENTION OF TYPE I DIABETES IN THE NOD MOUSE AND MAN$139,403
P01 · FY2000 · DK